The Valley Desk

Clinical trial reportNature communicationsPublished

Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label Phase I study in healthy volunteers

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania, The Wistar Institute. Affiliation source

Publication record

Type
Clinical trial report
Venue
Nature communications
Published
Subject terms
Animals; Humans; Mice; Rabies virus; Rabies; RNA; Influenza Vaccines; Rabies Vaccines; Antibodies, Viral; Vaccination; Adolescent; Adult
PubMed ID
39774967
PubMed Central ID
PMC11707033
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal